Indiana Animal Disease Diagnostic Laboratory partners with Gestalt Diagnostics to adopt PathFlow® for enhancing digital pathology capabilities.

SPOKANE, Wash., Jan. 20, 2026 /PRNewswire/ -- Gestalt, a recognized leader in digital pathology and AI-powered workflow solutions, is proud to announce that the Indiana Animal Disease Diagnostic Laboratory (ADDL) at Purdue University has joined its growing list of forward-thinking...

Gestalt has unveiled PathFlow Version 6, enhancing digital pathology with improved workflows and features, ensuring pathologists can diagnose effectively.

SPOKANE, Wash., Oct. 6, 2025 /PRNewswire/ -- Gestalt is proud to announce the release of PathFlow Version 6, the latest evolution of its award-winning digital pathology platform. This major update introduces a dynamic, high-powered field of view designed to elevate the diagnostic...

SPOKANE, Wash., Oct. 2, 2025 /PRNewswire/ -- Gestalt, a leader in digital pathology and AI-driven laboratory solutions, is proud to announce that Tulsa Medical Lab (TML) has selected PathFlow®as their digital pathology solution, marking a major step forward in the lab's strategy to...

SPOKANE, Wash., July 9, 2025 /PRNewswire/ -- Gestalt, a leading provider of AI-powered digital pathology solutions, showcased its AI-powered pathology platform, PathFlow, at the Spring 2025 DICOM WG-26 Interoperability Connectathon, confirming its readiness for real-world clinical...

At the Spring 2025 DICOM WG-26 Connectathon, Gestalt displayed its PathFlow platform, proving its readiness for integration in multi-vendor environments.

Gestalt Diagnostics has completed a Series A financing round, raising $7.5m for expanding its AI-powered PathFlow pathology platform.

The company will use the money in part to improve its flagship PathFlow digital pathology platform.

Gestalt Diagnostics has successfully closed a $7.5 million Series A funding round to enhance their AI-powered pathology platform, PathFlow, improving diagnostic capabilities.

AIRA Matrix and Gestalt have forged a strategic partnership to integrate AIRA Matrix’s AI-powered quality control solution, AIRAQC, into Gestalt’s PathFlow platform. Announced on March 24, 2025, this collaboration aims to boost diagnostic precision and efficiency in labs globally. AIRAQC uses artificial intelligence to streamline quality control, enabling quicker and more precise analysis in pathology. […]

The firms said that they will integrate Primaa's skin cancer testing algorithms with Gestalt's PathFlow digital pathology software platform.